Alkem Laboratories Limited (ALKEM) - Total Liabilities
Based on the latest financial reports, Alkem Laboratories Limited (ALKEM) has total liabilities worth Rs64.77 Billion INR (≈ $700.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Alkem Laboratories Limited - Total Liabilities Trend (2010–2025)
This chart illustrates how Alkem Laboratories Limited's total liabilities have evolved over time, based on quarterly financial data. See Alkem Laboratories Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Alkem Laboratories Limited Competitors by Total Liabilities
The table below lists competitors of Alkem Laboratories Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nedbank Group Ltd
JSE:NED
|
South Africa | ZAC1.35 Trillion |
|
SIGMASTAR TECH LTD
SHE:301536
|
China | CN¥2.29 Billion |
|
SODEXO S.A. ADR/ 1/5 EO 4
F:SJ70
|
Germany | €11.19 Billion |
|
JSW Infrastructure Limited
NSE:JSWINFRA
|
India | Rs86.66 Billion |
|
Shanghai Electric Power Co Ltd
SHG:600021
|
China | CN¥149.90 Billion |
|
Synovus Financial Corp
NYSE:SNV
|
USA | $54.65 Billion |
|
Technology One Ltd
AU:TNE
|
Australia | AU$440.70 Million |
|
Dpm Metals Inc.
AU:DPM
|
Australia | AU$509.27 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Alkem Laboratories Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALKEM market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.32 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alkem Laboratories Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alkem Laboratories Limited (2010–2025)
The table below shows the annual total liabilities of Alkem Laboratories Limited from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs52.57 Billion ≈ $568.58 Million |
+8.17% |
| 2024-03-31 | Rs48.60 Billion ≈ $525.64 Million |
+12.47% |
| 2023-03-31 | Rs43.22 Billion ≈ $467.37 Million |
-17.24% |
| 2022-03-31 | Rs52.22 Billion ≈ $564.72 Million |
+31.82% |
| 2021-03-31 | Rs39.61 Billion ≈ $428.39 Million |
+8.93% |
| 2020-03-31 | Rs36.37 Billion ≈ $393.28 Million |
+37.95% |
| 2019-03-31 | Rs26.36 Billion ≈ $285.10 Million |
-1.64% |
| 2018-03-31 | Rs26.80 Billion ≈ $289.87 Million |
+35.02% |
| 2017-03-31 | Rs19.85 Billion ≈ $214.69 Million |
+13.59% |
| 2016-03-31 | Rs17.48 Billion ≈ $189.00 Million |
-20.96% |
| 2015-03-31 | Rs22.11 Billion ≈ $239.12 Million |
+30.63% |
| 2014-03-31 | Rs16.93 Billion ≈ $183.05 Million |
+1.09% |
| 2013-03-31 | Rs16.74 Billion ≈ $181.07 Million |
+31.13% |
| 2012-03-31 | Rs12.77 Billion ≈ $138.09 Million |
-10.20% |
| 2011-03-31 | Rs14.22 Billion ≈ $153.77 Million |
+301.65% |
| 2010-03-31 | Rs3.54 Billion ≈ $38.29 Million |
-- |
About Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective… Read more